{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:34Z","timestamp":1754161594474,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Both hypophosphatemic osteomalacia and primary hyperparathyroidism (PHPT) can lead to hypophosphatemia, but their simultaneous occurrence in the same patient is exceedingly rare. This article reports a case of a 43-year-old female patient whose primary clinical manifestations included pain in the lumbosacral and scapular regions, restricted mobility, and biochemical findings of decreased serum phosphate levels with normal parathyroid hormone (PTH) levels. The patient\u2019s symptoms improved after treatment with active vitamin D supplementation, although neutral phosphate supplements were not administered. Eight years later, the patient\u2019s symptoms progressively worsened. Further investigations revealed elevated PTH levels and worsening hypophosphatemia. Neck contrast-enhanced ultrasonography and parathyroid radionuclide imaging both indicated nodules in the right parathyroid gland. Postoperative pathological examination confirmed the diagnosis of parathyroid adenoma. Whole-exome sequencing identified a heterozygous deletion in exon 11 of the PHEX gene, consistent with a diagnosis of X-linked hypophosphatemia (XLH).<\/jats:p>","DOI":"10.3389\/fendo.2025.1634377","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:10:37Z","timestamp":1753762237000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A case report of X-linked hypophosphatemia combined with primary hyperparathyroidism"],"prefix":"10.3389","volume":"16","author":[{"given":"YinQiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-2591.2022.02.001","article-title":"Guidelines for diagnosis and treatment of hypophosphatemic rickets\/osteomalacia in China","volume":"15","author":"Xu","year":"2022","journal-title":"Chin J Osteoporosis Bone Mineral Salt Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-2591.2014.03.002","article-title":"Guidelines for diagnosis and treatment of primary hyperparathyroidism","volume":"7","year":"2014","journal-title":"Chin J Osteoporosis Bone Mineral Salt Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/boneabs.7.p82","article-title":"Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets","volume":"11","author":"Tournis","year":"2011","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.06.025","article-title":"Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients","volume":"127","author":"DeLacey","year":"2019","journal-title":"Bone"},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","article-title":"Autonomous hyperparathyroidism in X-linked hypophosphataemia","volume":"42","author":"Knudtzon","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/ten.0b013e3181514e2b","article-title":"Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature","volume":"5","author":"Tournis","year":"2005","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00709-4","article-title":"FGF23 and hypophosphatemic rickets\/osteomalacia","volume":"19","author":"Takashi","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90411-5","article-title":"Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia","volume":"78","author":"Firth","year":"1985","journal-title":"Rep Two Cases Am J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000072524","article-title":"Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy","volume":"60","author":"Jeon","year":"2003","journal-title":"Horm Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-278184","article-title":"Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis","volume":"30","author":"Fan","year":"2016","journal-title":"FASEB J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0589","article-title":"Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status","volume":"95","author":"Carpenter","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00926-x","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1634377\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:10:39Z","timestamp":1753762239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1634377\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":13,"alternative-id":["10.3389\/fendo.2025.1634377"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1634377","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"article-number":"1634377"}}